Helicobacter Pylori Non-invasive Testing Market Revenue to Cross $800.04Mn, Globally, by 2028 to Growing at 4.4% CAGR – Study by The Insight Partners New York, Aug. 24, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market Forecast to 2028 – COVID-19 Impact...

Value of Bioanalytical Testing Services Market Estimated at US$ 8.95 Bn by 2031, TMR Report Wilmington, Delaware, United States, July 08, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: TMR study for bioanalytical testing services market statistics, estimates a CAGR of 15.7%...

Diazyme Laboratories, Inc. Receives Second FDA EUA for COVID-19 Antibody Test SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgM CLIA test. The Diazyme IgM test runs on...

Diazyme Laboratories, Inc. Receives FDA EUA for COVID-19 Antibody Test SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgG CLIA test. The Diazyme IgG test is run on...

Diazyme Announces Continued Availability of COVID-19 Laboratory Run Antibody Tests SAN DIEGO, Calif., May 22, 2020 (GLOBE NEWSWIRE) -- Diazyme is making a statement to clear any confusion due to FDA’s May 21 press release regarding delisted tests from the FDA FAQ website. Diazyme...